- Sections
- A - Nécessités courantes de la vie
- A61K - Préparations à usage médical, dentaire ou pour la toilette
- A61K 31/609 - Amides, p. ex. salicylamide
Détention brevets de la classe A61K 31/609
Brevets de cette classe: 177
Historique des publications depuis 10 ans
|
12
|
5
|
9
|
12
|
23
|
20
|
13
|
13
|
14
|
7
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Union Therapeutics A/S | 59 |
18 |
| Novo Nordisk A/S | 2275 |
5 |
| First Wave bio, Inc. | 26 |
4 |
| Board of Regents, The University of Texas System | 5917 |
3 |
| Arizona Board of Regents on Behalf of Northern Arizona University | 168 |
3 |
| Arven Ilac Sanayi Ve Ticaret A.S. | 95 |
3 |
| CEVA Sante Animale | 693 |
3 |
| Institut Curie | 601 |
3 |
| Institute for Cancer Research d/b/a The Research Institute of Fox Chase Cancer Center | 165 |
3 |
| The Translational Genomics Research Institute | 275 |
3 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2895 |
3 |
| Vanderbilt University | 1928 |
3 |
| VeroScience LLC | 68 |
3 |
| The Regents of the University of California | 20230 |
2 |
| AstraZeneca AB | 2857 |
2 |
| Pfizer Inc. | 3397 |
2 |
| Board of Supervisors of Louisiana State University and Agricultural and Mechanical College | 824 |
2 |
| Eurofarma Laboratorios S.A. | 37 |
2 |
| Health Research, Inc. | 341 |
2 |
| Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) | 337 |
2 |
| Autres propriétaires | 106 |